评估小儿耳鼻咽喉科医生超说明书使用环丙沙星-地塞米松的国家趋势与感知安全性
一项2022年1月至4月对美国小儿耳鼻咽喉科学会成员的15项横断面调查(163份完整回复,回复率26.6%)显示,156人(95.7%)报告超说明书使用环丙沙星-地塞米松(CPD),最常见适应证为气管肉芽(87.8%,n=137)和后鼻孔闭锁(82.1%,n=128)。受访者中三分之二对超说明书CPD的安全性感到「非常舒适」,99.4%(n=156)认为获益大于风险,7人(4.5%)报告不良事件。
要点
- 163份完整回复中156人(95.7%)报告超说明书使用CPD。
- 最常见适应证为气管肉芽(87.8%)和后鼻孔闭锁(82.1%)。
- 7名受访者(4.5%)报告局部过敏反应、库欣样症状等不良事件。
核心结论
- 研究结果提示超说明书CPD在小儿耳鼻咽喉科医生中常用,许多受访者认为其获益大于风险;结果为未来评估超说明书CPD的疗效与安全性及改善可及性建立基线。
研究设计与样本
- 15项横断面调查于2022年1月至4月发放给美国小儿耳鼻咽喉科学会成员,共163份完整回复,回复率26.6%;采用单变量分析比较超说明书CPD使用者与非使用者,并用多变量逻辑回归比较不同地区和执业类型的获取便利性。
主要发现
- 163份完整回复中156人(95.7%)报告超说明书使用CPD。
- 超说明书CPD最常见适应证为气管肉芽(87.8%,n=137)和后鼻孔闭锁(82.1%,n=128)。
- 与学术型独立儿童医院相比,获取便利性在中西部(OR=18.79,95%CI:3.63-1.24,p=0.001)和西部(OR=29.92,95%CI:3.55-682.00,p=0.006)显著增加,在三级转诊中心(OR=0.11,95%CI:0.01-0.64,p=0.041)和私人诊所(OR=0.04,95%CI:0.002-0.33,p=0.009)显著降低。
- 三分之二受访者对超说明书CPD的安全性感到「非常舒适」;99.4%(n=156)认为超说明书使用的获益大于风险。
- 7名受访者(4.5%)报告超说明书使用相关不良事件,如局部过敏反应、库欣样症状。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Off-label use of Ciprodex® (ciprofloxacin-dexamethasone: CPD), an antibiotic-steroid combination solution, in the airway has been reported by pediatric otolaryngologists with anecdotal success. We examined national trends regarding off-label CPD use including prevalence, common indications, prescriber patterns, adverse events, and accessibility. METHODS: 15-item cross-sectional survey was distributed to American Society of Pediatric Otolaryngology members from January-April 2022. Univariate analyses were performed to compare responses for users of off-label CPD versus non-users. Ease of access was compared across geographies and practice types using multivariate logistic regressions. RESULTS: Of the 163 complete responses (26.6% response rate), 156 (95.7%) reported using off-label CPD. Most common indications for off-label CPD were tracheal granulation (87.8%, n = 137) and choanal atresia (82.1%, n = 128). Ease of access was significantly increased in the Midwest (OR:18.79, 95%CI:3.63-1.24, p = 0.001) and West (OR:29.92, 95%CI:3.55-682.00, p = 0.006). Ease of access was significantly lower at tertiary referral centers (OR:0.11, 95%CI:0.01-0.64, p = 0.041) and private practices (OR:0.04, 95%CI:0.002-0.33, p = 0.009) compared to academic free-standing children's hospitals. Two-thirds of respondents reported feeling "Very Comfortable" with the safety profile of off-label CPD; 99.4% (n = 156) felt that the benefits outweighed the risks of off-label use. Seven respondents (4.5%) reported adverse events (e.g., local allergic reaction, cushingoid symptoms) from off-label use. CONCLUSIONS: Our findings (26.6% response rate) suggest that off-label CPD is commonly used by pediatric otolaryngologists, many of whom reported feeling that the benefits of off-label CPD outweigh the risks. Our results establish a baseline for future efforts to assess the efficacy and safety of off-label CPD and to improve its accessibility. LEVEL OF EVIDENCE: V Laryngoscope, 134:2922-2930, 2024.
引用
- Shah HP, Shah R, Lockwood D, et al. Assessing National Trends and Perceived Safety of Off-Label Ciprofloxacin-Dexamethasone Use by Pediatric Otolaryngologists. Laryngoscope. 2023. PMID: 38149706. doi:10.1002/lary.31211
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。